This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovations of Urs A Meyer
Introduction
Urs A Meyer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmacogenetics, particularly in the identification of genetic defects that affect drug metabolism. His work has implications for personalized medicine and drug testing.
Latest Patents
Urs A Meyer holds a patent for "P450db1 clones for identifying humans with genetic defect in drug." This patent involves a cloned cDNA encoding the debrisoquine 4-hydroxylase gene and a probe for identifying individuals with a genetic defect in the metabolism of certain drugs, using debrisoquine as a model. The patent also describes a simple assay for testing new drugs and humans.
Career Highlights
Urs A Meyer is associated with the United States of America as represented by the Department of Health. His work has been pivotal in advancing the understanding of drug metabolism and its genetic underpinnings.
Collaborations
He has collaborated with notable colleagues such as James P Hardwick and Frank J Gonzalez, contributing to the advancement of research in pharmacogenetics.
Conclusion
Urs A Meyer is a distinguished inventor whose work in pharmacogenetics has the potential to transform drug testing and personalized medicine. His contributions are invaluable to the field and continue to influence future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile